Two Sigma Investments, LP 9 Meters Biopharma, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.21 - $0.32 $178,341 - $271,758	849,246 Added 7611.78%	860,403 $185,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $76,472 - $188,240	-294,125 Reduced 96.35%	11,157 $3,000
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $5,822 - $11,198	-11,198 Reduced 3.54%	305,282 $183,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $269,008 - $420,918	316,480 New	316,480 $310,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $837,583 - $1.15 Million	-813,188 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $284,853 - $410,847	273,898 Added 50.79%	813,188 $895,000
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $453,003 - $1.16 Million	539,290 New	539,290 $631,000
Q4 2020 Feb 16, 2021	SELL	$0.65 - $1.11 $73,073 - $124,786	-112,420 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.48 - $0.84 $53,961 - $94,432	112,420 New	112,420 $92,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.